Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-868

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Carmot Therapeutics, Inc · Phase 2 · Completed · Enrollment 103

NCT05110846

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Placebon/rn/rn/rn/r
CT-868 1.75 mgn/rn/rn/rn/r
CT-868 4.0 mgn/rn/rn/rn/r

Not shown

  • Placebo: endpoint not reported
  • CT-868 1.75 mg: endpoint not reported
  • CT-868 4.0 mg: endpoint not reported